Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in TaxesOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Change in Receivables (2018 - 2019)

Historic Change in Receivables for China SXT Pharmaceuticals (SXTC) over the last 2 years, with Q3 2019 value amounting to $4.6 million.

  • China SXT Pharmaceuticals' Change in Receivables rose 1744.49% to $4.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $4.6 million, marking a year-over-year increase of 1744.49%. This contributed to the annual value of $257085.0 for FY2025, which is 2001.64% down from last year.
  • Latest data reveals that China SXT Pharmaceuticals reported Change in Receivables of $4.6 million as of Q3 2019, which was up 1744.49% from $4.2 million recorded in Q1 2019.
  • In the past 5 years, China SXT Pharmaceuticals' Change in Receivables ranged from a high of $4.6 million in Q3 2019 and a low of $2.6 million during Q1 2018